Clene CLNN
NASDAQ CLNN
$4.20 -0.21 (-4.88%)
At close: Nov 11, 2026 · 4:00 PM EST

Clene (CLNN) Return on Equity [ROE] (2021 - 2024)

Updated

Clene (CLNN) recorded Return on Equity [ROE] of -1738.36% in FY2024, down 1142.90 percentage points from -595.47% in FY2023.

Analysis

Clene (CLNN) Return on Equity [ROE] (2021 - 2024) Analysis & Trends

Starting with FY2021, Clene's Return on Equity [ROE] history includes 4 years.

  • Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -1587.80 percentage points (FY2021 to FY2024).
  • Per Business Quant data, CLNN's Return on Equity [ROE] was -595.47% in FY2023 (-217.57 pp), -377.90% in FY2022 (-227.33 pp) and -150.56% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Clene 62.68 Mn 32.00 Mn 40,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3,797.29%
Mar 31, 2024 599.91%
Dec 31, 2023 300.90%
Sep 30, 2023 -188.11%
Jun 30, 2023 -491.03%
Mar 31, 2023 -3,523.43%
Jun 30, 2022 2,108.94%
Mar 31, 2022 227.19%
Dec 31, 2021 -106.95%
API Access

Clene Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLNN&period=max&api_key=YOUR_API_KEY